Syndicate

Latest California Healthline Stories

Federal Grants ‘A Lifesaver’ In Opioid Fight, But States Still Struggle To Curb Meth

The federal government has doled out at least $2.4 billion in state grants since 2017 to address the opioid epidemic, which killed 47,600 people in the U.S. that year alone. But local officials note that drug abuse problems seldom involve only one substance.

In Combating Surprise Bills, Lawmakers Miss Sky-High Air Ambulance Costs

The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.

A Proposal To Make It Harder For Kids To Skip Vaccines Gives Powerful Voices Pause

California lawmakers are debating whether to tighten the rules on childhood vaccinations and give the ultimate say to state public health officials. But questions are emerging from unexpected quarters: the state medical board and Democratic Gov. Gavin Newsom.

KHN’s ‘What The Health’: Who Will Pay To Fix Problem Of Surprise Medical Bills?

Lawmakers and patients want to eliminate “surprise” out-of-network medical bills. Hospitals, doctors and insurers say they want to eliminate them, too, but their opposition to one another’s proposals could complicate legislative efforts. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus the latest in news about reproductive health and health care sharing ministries.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.